Kwality Pharmaceuticals Limited

NSE: KPL

₹2,526.4

+0.79%EOD · 11 Jun

Market Cap

—

52W Range

₹2600 / ₹1561

Volume

14K

1Y Return

—

P/B Ratio

8.5

ROE

22.7%

Debt / Equity

39.54

Technical Indicators

35d data — partial · objective math, not advice

Returns

+0.8%

+6.5%

+37.6%

—

RSI (14)

74 Overbought

Moving Averages (price vs MA)

20-DMA

₹2277

above

50-DMA

—

150-DMA

—

200-DMA

—

From 52W High

-2.8%

From 52W Low

+61.8%

Support (20D)

₹1980

Resistance (20D)

₹2600

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

We Think That There Are Issues Underlying Kwality Pharmaceuticals' (NSE:KPL) Earnings
simplywall.st· 27 May
KPL Stock Price and Chart — NSE:KPL
TradingView· 20 Apr
KWALITY PHARMACEUTICALS L Share Price Today - Live KPL Stock Price for NSE/BSE
Upstox· 5 May
Yuken India Limited (YUKEN) stock price prediction 2026–2030
Bitget· 10 Feb
Waaree Energies shares rise over 1% ahead of Q2 results; five things you need to know
Upstox· 15 Oct
KPL receives nod to sell its anti-cancer drug Bleomycin 15 IU in Mexico
Business Standard· 18 Aug

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.